ALLMedicine™ Anterior Circulation Stroke Center

Mar 7th, 2023 - Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) has been the only proven therapy for acute ischemic stroke (AIS) for almost 20 years. Since December 2014 a new era in acute stroke treatment has begun: randomiz...

Mar 6th, 2023 - Increased blood pressure variability (BPV) has consistently been associated with two to three times higher risk of disability or mortality after acute ischemic stroke (AIS) in retrospective analyses, independent of mean blood pressure. Our central...

Mar 1st, 2023 - Two trials in Chinese population showed that endovascular treatment (EVT) alone was noninferior to alteplase follow by EVT at 90 days. However, results of long-term clinical outcomes remain unknown. We reported the results of prespecified 18-month...

Mar 1st, 2023 - The endovascular treatment procedure in tandem occlusions (TO) is complex compared to single occlusion (SO) and optimal management remains uncertain. The aim of this study was to identify clinical and procedural factors that may be associated to e...

Feb 21st, 2023 - Methodology: This study will conducted at a tertiary level hospital with prior ethical approval from the institutional review committee and consent from the patient will taken with the consent form. It was a retrospective cross-sectional study des...

Mar 7th, 2023 - Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) has been the only proven therapy for acute ischemic stroke (AIS) for almost 20 years. Since December 2014 a new era in acute stroke treatment has begun: randomiz...

Mar 6th, 2023 - Increased blood pressure variability (BPV) has consistently been associated with two to three times higher risk of disability or mortality after acute ischemic stroke (AIS) in retrospective analyses, independent of mean blood pressure. Our central...

Feb 21st, 2023 - Methodology: This study will conducted at a tertiary level hospital with prior ethical approval from the institutional review committee and consent from the patient will taken with the consent form. It was a retrospective cross-sectional study des...

Feb 8th, 2023 - The ANGEL-REBOOT is a multicentered, prospective, randomized, open-label, blinded end-point (PROBE design) study. A total of approximately 348 patients within 24 hours of symptom onset of acute ischemic stroke (NIHSS≥6), who has the imaging eviden...

Feb 8th, 2023 - Posterior circulation stroke accounts for 20-25% of all ischemic strokes, with an annual adjusted incidence of 18 per 100,000 person-years. Compared with anterior circulation stroke, posterior circulation stroke is less studied and has poor neurol...

Jun 2nd, 2022 - Small but vulnerable carotid plaques appear to be a more important cause of stroke than previously thought, a new study suggests. Results of the Carotid Plaque Imaging in Acute Stroke (CAPIAS) study show that patients with complicated carotid arte...

Jan 25th, 2022 - In a guidance update, the American Heart Association (AHA) said healthcare providers should quickly don PPE before performing CPR on people with suspected COVID-19. (Circulation: Cardiovascular Quality and Outcomes) A small risk of carditis associ...

Apr 24th, 2017 - BOSTON – Ultra-fast door-to-needle times of 10 minutes or less for intravenous acute ischemic stroke thrombolysis can be safely achieved in carefully selected cases, according to a review of cases at an Austrian teaching hospital. Raffi Topakian,.

Apr 24th, 2017 - BOSTON – Ultra-fast door-to-needle times of 10 minutes or less for intravenous acute ischemic stroke thrombolysis can be safely achieved in carefully selected cases, according to a review of cases at an Austrian teaching hospital. Raffi Topakian,.

Nov 17th, 2016 - The US Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire stent retriever device, Medtronic has announced. The move will allow the marketing of the device as an initial therapy for acute ischemic strokes for pa...